The classification of adeno-pituitary tumor was deeply revised over the last 20 years, in
order to better describe the variable and complex biological and clinical behavior of these …

Pituitary adenoma/pituitary neuroendocrine tumors (PitNETs) are the second most common
primary intracranial tumor and the most frequent neuroendocrine tumors/neoplasms of the …

Simple Summary Pituitary adenomas are highly prevalent intracranial neoplasms that can
be locally invasive in up to half of cases. Consequently, using the term “PitNETs”(pituitary …

In the 2022 fifth edition of the WHO Classification of Endocrine Tumours and of Central
Nervous System Tumours, pituitary adenomas are reclassified as neuroendocrine tumours …

Abstract The 2017 World Health Organization (WHO) classification proposes to type and
subtype primary adenohypophyseal tumours according to their cell lineages with the aim to …

Pituitary neuroendocrine tumors (PitNETs) were previously classified as adenomas and
accordingly referred to as pituitary adenomas. PitNETs have a lifetime prevalence of 5–10 …

Abstract The World Health Organization (WHO) updated the classification of pituitary tumors
in 2022. The new classification presents detailed histological subtyping of a pituitary …

The immunohistochemistry (IHC) characterization of pituitary transcription factors (PTFs)
PIT1, TPIT, and SF1, which enable the identification of three different adenohypophyseal cell …

The pituitary is a master gland responsible for the modulation of critical endocrine functions.
Pituitary neuroendocrine tumours (PitNETs) display a considerable prevalence of 1/1106 …

Pituitary neuroendocrine tumors (PitNETs) are the third most frequently diagnosed
intracranial tumors, with nonfunctioning PitNETs (nfPitNETs) accounting for 30% of all …